Endometrial hyperplasia epidemiology and demographics: Difference between revisions
Line 16: | Line 16: | ||
*There is no [[racial]] predilection to [[endometrial hyperplasia]]. | *There is no [[racial]] predilection to [[endometrial hyperplasia]]. | ||
===Gender=== | ===Gender=== | ||
*[[endometrial hyperplasia]] affects women. | *[[endometrial hyperplasia]] affects [[women]]. | ||
==References== | ==References== |
Latest revision as of 11:18, 8 May 2019
Endometrial hyperplasia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Endometrial hyperplasia epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Endometrial hyperplasia epidemiology and demographics |
FDA on Endometrial hyperplasia epidemiology and demographics |
CDC on Endometrial hyperplasia epidemiology and demographics |
Endometrial hyperplasia epidemiology and demographics in the news |
Blogs on Endometrial hyperplasia epidemiology and demographics |
Risk calculators and risk factors for Endometrial hyperplasia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Swathi Venkatesan, M.B.B.S.[2]
Overview
Women of all age groups may develop endometrial hyperplasia. However, endometrial hyperplasia is more common in postmenopausal women.
Epidemiology and Demographics
Incidence
- The incidence endometrial hyperplasia is approximately 133 per 100,000 woman per year worldwide. [1]
Age
- The incidence of endometrial hyperplasia increases with age; the median age at diagnosis is 50-54 years.[1]
- The incidence of atypical hyperplasia is greatest in 60–64 year old women.[1]
Race
- There is no racial predilection to endometrial hyperplasia.
Gender
- endometrial hyperplasia affects women.
References
- ↑ 1.0 1.1 1.2 Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, Allison K, Voigt LF, Weiss NS (June 2009). "Incidence of endometrial hyperplasia". Am. J. Obstet. Gynecol. 200 (6): 678.e1–6. doi:10.1016/j.ajog.2009.02.032. PMC 2692753. PMID 19393600.